You have read all your free articles, to continue reading subscribe to read the rest of this content.
Sweden’s Recipharm AB issued convertible bonds with a nominal value of EUR 50 million as part of the financing of the acquisition of the Corvette Pharmaceutical Services Group completed Oct. 1, 2014. The bonds can be converted into up to 5,030,549 class B-shares. The holders of the convertible bonAlready a…
Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IO. The national research and innovation project Cancer IO started in May as a part of Business Finland’s Personalized Health Program. The project will develop new solutAlready a subscriber Login You have read…
AstraZeneca has entered into an agreement with TerSera Therapeutics (TerSera) for the commercial rights to Zoladex (goserelin acetate implant) in the US and Canada. Zoladex is an injectable luteinising hormone-releasing hormone agonist, used to treat prostate cancer, breast cancer and certain benAlready a subscriber Login You have read all your…
The Board of Directors and Nomination Committee have proposed the appointment of Anna Ljung as the new CEO of Moberg Pharma, while current CEO Peter Wolpert will transition to a role as Executive Chairman of the Board of Directors. The divestment of the OTC business on March 29, 2019 represents…
